Cargando…

New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease

The immune system has been increasingly recognized as a major contributor in the pathogenesis of Parkinson’s disease (PD). The double-edged nature of the immune system poses a problem in harnessing immunomodulatory therapies to prevent and slow the progression of this debilitating disease. To tackle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Jolene Su Yi, Chao, Yin Xia, Rötzschke, Olaf, Tan, Eng-King
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730912/ https://www.ncbi.nlm.nih.gov/pubmed/33291304 http://dx.doi.org/10.3390/ijms21239302

Ejemplares similares

Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020)

Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020)

The role of IgA in COVID-19
por: Chao, Yin Xia, et al.
Publicado: (2020)

Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1
por: Tan, Jolene Su Yi, et al.
Publicado: (2022)

Historical Perspective: Models of Parkinson’s Disease
por: Chia, Shyh Jenn, et al.
Publicado: (2020)

Parkinson’s disease following COVID-19: causal link or chance occurrence?
por: Li, Wei-Shan, et al.
Publicado: (2020)

Role of MicroRNAs in Parkinson’s Disease
por: Goh, Suh Yee, et al.
Publicado: (2019)

Targeting the inflammasome in Parkinson’s disease
por: Su, Qi, et al.
Publicado: (2022)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Evidence of Inflammatory System Involvement in Parkinson's Disease
por: Chao, Yinxia, et al.
Publicado: (2014)

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2019)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

Mitophagy and reactive oxygen species interplay in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence
por: Peeraully, Tasneem, et al.
Publicado: (2012)

Genetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease
por: Nott, Alexi, et al.
Publicado: (2023)

Leucine-Rich Repeat Kinase 2-Linked Parkinson’s Disease: Clinical and Molecular Findings
por: Kumari, Udhaya, et al.
Publicado: (2010)

Parkinson's Disease Caregiver Strain in Singapore
por: Tan, Siok-Bee, et al.
Publicado: (2020)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

New Insights into the Mechanisms of Chaperon-Mediated Autophagy and Implications for Kidney Diseases
por: Yuan, Zhen, et al.
Publicado: (2022)

Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
por: Weil, Rimona S, et al.
Publicado: (2020)

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Impact of Covid-19 on research and training in Parkinson's disease
por: Wan, Yi-Min, et al.
Publicado: (2022)

Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
por: Liu, Wei, et al.
Publicado: (2022)

Case-control study of hypertension and Parkinson’s disease
por: Ng, Yuen-Fann, et al.
Publicado: (2021)

MDPD: an integrated genetic information resource for Parkinson's disease
por: Tang, Suisheng, et al.
Publicado: (2009)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease
por: Yong, Ming-Hui, et al.
Publicado: (2011)

Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD)
por: Zhou, Zhi Dong, et al.
Publicado: (2016)

Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm
por: Yong, Ming-Hui, et al.
Publicado: (2013)

The Characteristics of Patients Associated With High Caregiver Burden in Parkinson's Disease in Singapore
por: Tan, Mark M. J., et al.
Publicado: (2019)

Impact of COVID‐19 pandemic on patients with Parkinson's disease: A meta‐analysis of 13,878 patients
por: Mai, Aaron Shengting, et al.
Publicado: (2022)

Association Between Parkinson’s Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Chua, Shaun Kai Kiat, et al.
Publicado: (2022)

Genetic Variations of GAK in Two Chinese Parkinson’s Disease Populations: A Case-Control Study
por: Tseng, Wei-En Johnny, et al.
Publicado: (2013)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
por: Metta, Vinod, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tqmh7irca4gvsrfsmc9nmia73t